Articles

  • 3 weeks ago | medscape.com | Karen Blum

    On a cold Wednesday morning in January, Ruben Olivares, MD, sat down at a computer workstation in Cleveland to perform surgery on a man with prostate cancer. Olivares, a urologist at Cleveland Clinic, Cleveland, directed a robot to send high-intensity, focused ultrasound waves to the tumor. But this time, the patient was not in a nearby operating room, or in the same building — or even the same country.

  • 3 weeks ago | myadlm.org | Karen Blum

    In sepsis management, time is of the essence. Every hour that passes before a patient is identified and started on treatment puts them at risk for organ failure or death. Knowing this, some clinicians have been trying new methods to increase earlier sepsis detection and management by developing algorithms that employ artificial intelligence (AI) to evaluate laboratory values and other data to alert providers to the presence of sepsis, which affects some 50 million people globally.

  • 3 weeks ago | healthjournalism.org | Karen Blum

    Medical device manufacturers are required by the U.S. Food and Drug Administration to report within 30 days any adverse safety events like malfunctions that could injure someone. The agency compiles these events in a centralized database called the Manufacturer and User Facility Device Experience (MAUDE) and uses the information to decide whether to communicate any safety concerns to the health care community and/or the public, or pursue any other regulatory actions including recalls.

  • 1 month ago | myadlm.org | Karen Blum

    Last July, when the Food and Drug Administration (FDA) approved a blood-based test for colorectal cancer screening, the test joined the ranks of growing options available — from traditional colonoscopy to stool-based testing — to try to detect these cancers and their precursors. While the test’s sensitivity lags behind some other screening options, it could prove to be a more attractive option for people not currently engaging in screening, experts say.

  • 1 month ago | pharmacypracticenews.com | Karen Blum

    Counseling survivors of melanoma on sun protection and skin health is an important role for pharmacists, said Lisa Holle, PharmD, BCOP, FHOPA, FISOPP, a clinical professor of pharmacy practice at the University of Connecticut School of Pharmacy, in Storrs. “This cannot be emphasized enough,” Dr. Holle said.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
5
Tweets
1
DMs Open
No
Karen Blum
Karen Blum @karenblum27
23 Apr 15

Down a panelist for today's 2 pm tech tools talk. Know about mobile phone use for video and want to sub? Call Karen 443-540-2197. #ahcj15